Jincheng Pharm(SZ:300233)2022-12-07 08:26Group 1: Company Overview - Jincheng Pharmaceutical has a diverse product range, including approved chemical drugs such as Nitrofurantoin Vaginal Gel Capsules and Pidotimod Dispersible Tablets, which have significant market potential [2] - The company possesses self-supply capabilities for raw materials, ensuring good quality assurance for its products [2] - Jincheng employs a combined marketing model of distribution and direct sales, supported by academic promotion and brand marketing strategies [2] Group 2: Key Products - The main products of Jincheng Pharmaceutical focus on gynecological and immune-regulating medications, with Nitrofurantoin Vaginal Gel Capsules being a leading product in the domestic market, holding the top market share across 34 provinces [3] - Pidotimod Dispersible Tablets, aimed at immune regulation, also lead the market among four main manufacturers [3] Group 3: Business Operations - The pricing and market demand for cephalosporin antibiotics remain stable [3] - Recent share reductions by company executives were attributed to personal financial needs rather than a lack of confidence in the company, with management expressing optimism about future development [3] Group 4: Future Development - Jincheng Pharmaceutical plans to utilize various development strategies, including potential acquisitions of companies that align with its growth direction and industrial goals [4]